医疗机器人设备制造商THINK Surgical获得高达6500万美元的债务融资-动脉网

THINK Surgical Secures up to $65 Million of Growth Capital

CISION 等信源发布 2026-07-15 00:00



可切换为仅中文







FREMONT, Calif.

加利福尼亚州弗里蒙特

，

July 14, 2026

2026年7月14日

/PRNewswire/ -- THINK Surgical, Inc., a leading innovator of orthopedic surgical robots, today announced it has entered into a debt facility with Symbiotic Capital which will provide up to $65 million of growth capital. The facility provided an initial funded tranche of $25 million, with an additional $15 million based on achievement of certain milestones, and up to $25 million of discretionary capital..

/美通社/ -- 骨科手术机器人领域的领先创新企业THINK Surgical, Inc.今日宣布，已与Symbiotic Capital达成一项债务融资安排，将获得高达6,500万美元的增长资本。该融资安排包括首期已拨付的2,500万美元，基于特定里程碑达成情况可额外获得1,500万美元，以及最高2,500万美元的酌情资本。

继续阅读

TMINI Miniature Robotic System

TMINI 微型机器人系统

Symbiotic Capital

共生资本

The proceeds will be used by THINK to continue to advance its dual channel commercial strategy for its TMINI

THINK 将把收益用于继续推进其 TMINI 产品的双渠道商业战略。

Miniature Robotic System, which is currently compatible with approximately 70% of the market share for total knee implants.

微型机器人系统，目前兼容约70%市场份额的全膝关节植入物。

Stuart Simpson, President, and Chief Executive Officer of THINK Surgical said 'This facility, combined with recent additional investments by our existing investors, will allow us to continue our significant growth and development of TMINI, and is expected to fully finance the Company to profitability.' .

THINK Surgical 总裁兼首席执行官斯图尔特·辛普森表示：“该设施，加上我们现有投资者近期的追加投资，将使我们能够持续推进 TMINI 的显著增长与开发，并预计为公司提供实现盈利所需的全部资金。”

'We are excited about TMINI's potential to advance surgical robotics in the field of orthopedics, and we are impressed by the compelling value proposition it offers to both physicians and patients,' said Himani Bhalla, Senior Managing Director and Chief Investment Officer of Symbiotic Capital.

“我们对TMINI在推动骨科手术机器人领域发展方面的潜力感到兴奋，并为其向医生和患者提供的极具吸引力的价值主张所折服。”Symbiotic Capital高级董事总经理兼首席投资官希曼尼·巴拉（Himani Bhalla）表示。

Piper Sandler served as financial advisor to THINK on the transaction.

派珀·桑德勒在此次交易中担任THINK的财务顾问。

About THINK Surgical, Inc.

关于THINK Surgical, Inc.

THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon.

THINK Surgical, Inc. 是一家总部位于美国的私营技术创新企业，专注于开发并营销骨科手术机器人。THINK Surgical 的机器人是开放平台，支持来自多家制造商的植入物品牌，使外科医生能够自主选择植入物。

THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology. Please refer to the instructions for use for the TMINI Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions.

THINK Surgical 积极与全球医疗保健专业人士合作，优化我们的骨科产品，通过精准、准确和智能的技术改善患有晚期关节疾病患者的生活。有关 TMINI 微型机器人系统的完整适应症、禁忌症、警告和注意事项列表，请参阅其使用说明书。

For additional product information, please visit .

如需更多产品信息，请访问。

www.thinksurgical.com

。

THINK Surgical and TMINI are registered trademarks of THINK Surgical, Inc.

THINK Surgical 和 TMINI 是 THINK Surgical, Inc. 的注册商标。

About Symbiotic Capital (symbcap.com)

关于共生资本（symbcap.com）

Symbiotic Capital is a healthcare credit firm that brings together decades of experience across healthcare, finance, and entrepreneurship. Our integration into a global healthcare ecosystem empowers us to provide lending solutions to fuel the growth of established healthcare companies around the world..

Symbiotic Capital 是一家医疗健康信贷公司，汇聚了我们在医疗健康、金融和创业领域数十年的经验。我们融入全球医疗健康生态系统，使我们能够为全球成熟的医疗健康公司提供融资解决方案，助力其增长。

Healthcare Credit. For Science, By Science.

医疗信贷。为科学而生，由科学驱动。

For more information, please visit

欲了解更多信息，请访问

www.symbcap.com

。

Information repurposed from THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT

信息改编自《骨科行业年度报告》

published by ORTHOWORLD

由 ORTHOWORLD 出版

Inc.